<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Bon Natural Life Ltd — News on 6ix</title>
<link>https://6ix.com/company/bon-natural-life-ltd</link>
<description>Latest news and press releases for Bon Natural Life Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 31 Mar 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/bon-natural-life-ltd" rel="self" type="application/rss+xml" />
<item>
<title>BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-unveils-strategic-partnership-with-tigerbone-group-to-launch-new-natural-health-initiatives</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-unveils-strategic-partnership-with-tigerbone-group-to-launch-new-natural-health-initiatives</guid>
<pubDate>Tue, 31 Mar 2026 04:00:00 GMT</pubDate>
<description>XI'AN, China, March 31, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions</description>
</item>
<item>
<title>BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-breakthrough-development-of-apple-bio-electronic-mask-clinical-data-exceeds-expectations-targeting-dollar100b-medical-aesthetics-market</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-breakthrough-development-of-apple-bio-electronic-mask-clinical-data-exceeds-expectations-targeting-dollar100b-medical-aesthetics-market</guid>
<pubDate>Thu, 19 Feb 2026 05:00:00 GMT</pubDate>
<description>XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in</description>
</item>
<item>
<title>BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-partners-changan-pilot-launch-140000514</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-partners-changan-pilot-launch-140000514</guid>
<pubDate>Tue, 17 Feb 2026 14:00:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, today announced the establishment of the BON & Pilot Joint Laboratory for Natural Ingredients and Bio-Manufacturing (the "Joint Laboratory"). The Joint Laboratory was inaugurated on December 18, 2025 through a collaboration between the Company's domestic operating subsidiary, Xi'an App-Chem Bio-Tech Co., Ltd., and Shaanxi Chang'an Pilot Life Scien</description>
</item>
<item>
<title>BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-unveils-kombucha-inspired-product-090000923</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-unveils-kombucha-inspired-product-090000923</guid>
<pubDate>Wed, 10 Dec 2025 09:00:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced the launch of a new health-focused kombucha-inspired product and a strategic collaboration with Shaanxi Qingshengyuan Health Industry Co., Ltd. ("Qingshengyuan"), a leading distributor of functional health products in China focusing on digestive and metabolic wellness. The two parties entered into a non-exclusive strategic</description>
</item>
<item>
<title>BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announced-next-gen-tea-144100708</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announced-next-gen-tea-144100708</guid>
<pubDate>Tue, 25 Nov 2025 14:41:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 36 months with a total contract value of US$26 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's second-generati</description>
</item>
<item>
<title>BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-dollar18-million-cooperation-agreement-for-innovative-second-generation-apple-series-health-products</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-dollar18-million-cooperation-agreement-for-innovative-second-generation-apple-series-health-products</guid>
<pubDate>Tue, 09 Sep 2025 04:00:00 GMT</pubDate>
<description>XI'AN, China, Sept. 9, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the</description>
</item>
<item>
<title>BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-identification-promising-weight-123000588</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-identification-promising-weight-123000588</guid>
<pubDate>Tue, 02 Sep 2025 12:30:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its AI-Powered new drug research and development (R&D) platform. Preliminary tests demonstrate that these compounds exhibit significant activity in weight management, with key efficacy indicators outperforming current</description>
</item>
<item>
<title>BON Announces Reciept of Nasdaq Compliance Letter</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-reciept-nasdaq-compliance-130000815</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-reciept-nasdaq-compliance-130000815</guid>
<pubDate>Tue, 05 Aug 2025 13:00:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced reciept of compliance notification from the Nasdaq Stock Market LLC.</description>
</item>
<item>
<title>BON Launches AI-Powered New Drug Research and Development</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-launches-ai-powered-drug-130000790</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-launches-ai-powered-drug-130000790</guid>
<pubDate>Wed, 30 Jul 2025 13:00:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced the official launch of its AI-driven drug research and development (R&D) business. Leveraging its extensive library of natural compounds - many derived from Traditional Chinese Medicine (TCM) - the Company will apply artificial intelligence algorithms to identify high potential lead compounds, marking a significant ev</description>
</item>
<item>
<title>BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-22-million-distribution-130000773</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-22-million-distribution-130000773</guid>
<pubDate>Mon, 21 Jul 2025 13:00:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural health and personal care industries, today announced it has entered into a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan"). The term of the agreement is 36 months with a total contract value of US$22 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute Bon's natural weight loss produ</description>
</item>
<item>
<title>BON Announces Nasdaq Compliance</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-nasdaq-compliance-130000449</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-nasdaq-compliance-130000449</guid>
<pubDate>Mon, 14 Jul 2025 13:00:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced that it has regained compliance with Nasdaq's continued listing requirements.</description>
</item>
<item>
<title>Bon Announces Breakthrough Order for $16 Million Gut-Health Products</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-breakthrough-order-16-120000326</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-breakthrough-order-16-120000326</guid>
<pubDate>Wed, 02 Jul 2025 12:00:00 GMT</pubDate>
<description>Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solutions provider in the natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a leading wellness company in China ("Huahai Keyuan"). The term of the agreement is 24 months with a total contract value of up to US$16 million. Pursuant to the agreement, Huahai Keyuan will market, sell and distribute BON's n</description>
</item>
<item>
<title>Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-natural-life-announces-distribution-130000578</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-natural-life-announces-distribution-130000578</guid>
<pubDate>Mon, 16 Jun 2025 13:00:00 GMT</pubDate>
<description>XI’AN, China, June 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“Bon” or the “Company”), a leading bio-ingredient solutions provider for natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Tianjin Merrill-Youli Trading Co., Ltd., a prominent Asia-Pacific fragrance chemical distributor (“Merrill-Youli”). The term of the agreement is 36 months with a total contract value of up to US$18 million. Pursuant to the agr</description>
</item>
<item>
<title>BON Announces Share Repurchase Program for up to US$1.0 Million</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-share-repurchase-program-130000521</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-share-repurchase-program-130000521</guid>
<pubDate>Tue, 03 Jun 2025 13:00:00 GMT</pubDate>
<description>XI’AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced its board of directors approved a share repurchase program pursuant to which the Company may purchase up to $1.0 million of its Class A ordinary shares. Under the share repurchase program, the Company is authorized to repurchase its shares from time to time in the open market.</description>
</item>
<item>
<title>BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-launch-tea-pigment-130000639</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-launch-tea-pigment-130000639</guid>
<pubDate>Thu, 22 May 2025 13:00:00 GMT</pubDate>
<description>XI’AN, China, May 22, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive sales cooperation agreement with Shanghai Risesun International Trade Co., Ltd., a leading functional ingredient distributor in China. The term of the Agreement is 24 months with a total contract value of US$ 24 million. Pursuant to the agreement, Shanghai Rises</description>
</item>
<item>
<title>BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-launch-postbiotic-hypoglycemic-130000249</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-launch-postbiotic-hypoglycemic-130000249</guid>
<pubDate>Fri, 16 May 2025 13:00:00 GMT</pubDate>
<description>XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with Beijing Huahai Keyuan (Tech) Co., Ltd., a leading functional ingredient distributor in China. The term of the agreement is 36 months with a total contract value of 32 million US dollars. Pursuant to the agreement, Beijing Huahai Keyuan will ser</description>
</item>
<item>
<title>Bon Natural Life Limited Announces Effectiveness of Reverse Stock Split</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-natural-life-limited-announces-101500883</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-natural-life-limited-announces-101500883</guid>
<pubDate>Thu, 15 May 2025 10:15:00 GMT</pubDate>
<description>XI’AN, China, May 15, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that it will effect a 1-for-25 reverse stock split ("Reverse Stock Split") of its authorized, issued and outstanding Class A ordinary shares, par value $0.001 per share. The Reverse Stock Split will become effective at 12:01a.m., Eastern Time, on May 19, 2025. At s</description>
</item>
<item>
<title>BON Debuts Groundbreaking Broccoli-Derived Sleep Wellness Line, Reshaping the Sleep Health Market through Innovative Technology</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-debuts-groundbreaking-broccoli-derived-131500551</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-debuts-groundbreaking-broccoli-derived-131500551</guid>
<pubDate>Tue, 13 May 2025 13:15:00 GMT</pubDate>
<description>XI’AN, China, May 13, 2025 (GLOBE NEWSWIRE) -- BON Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions for the natural health and personal care sectors, today announced the groundbreaking launch of its sleep health product series. Developed using the proprietary “Glucoraphanin-Myrosinase” delivery system (patent-pending), the Company intends for this product to dramatically enhance the bio-activity (the extent to which something is absorbed</description>
</item>
<item>
<title>Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-natural-life-limited-announces-201000439</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-natural-life-limited-announces-201000439</guid>
<pubDate>Fri, 02 May 2025 20:10:00 GMT</pubDate>
<description>XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, 2025, the Company received a letter (the “Notification Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it was not in compliance with Nasdaq Listing Rule 5450(a)(1)</description>
</item>
<item>
<title>BON Announces Apple Polyphenol Commercial Order Signed</title>
<link>https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-apple-polyphenol-commercial-110000767</link>
<guid isPermaLink="true">https://6ix.com/company/bon-natural-life-ltd/news/bon-announces-apple-polyphenol-commercial-110000767</guid>
<pubDate>Fri, 11 Apr 2025 11:00:00 GMT</pubDate>
<description>XI'AN, China, April 11, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a groundbreaking 24-month supply agreement worth $12M with Shanghai Yunsheng, China's premier functional ingredients distributor, to co-develop next-generation apple polyphenol-infused health solutions. The partnership leverages BON's patented extraction technology to deliver scien</description>
</item>
</channel>
</rss>